EFFECT OF STARCH HYDROLYSATES IN THE PROCESS OF DISSOLUTION OF SOLIDS

Similar documents
SOLUBILITY OF SELECTED DERIVATIVES OF 1,4-BENZODIAZEPINE-2-ONE IN THE PRESENCE OF PVP

Formulation and Evaluation of Tinidazole Syrup Made by Mixed Solvency Concept Technique

International Journal of Research in Pharmaceutical and Nano Sciences Journal homepage:

ENHANCEMENT OF SOLUBILITY OF BICALUTAMIDE DRUG USING SOLID DISPERSION TECHNIQUE

ISSN: X CODEN: IJPTFI Available Online through Research Article

STUDIES ON EFFECT OF BINDERS ON ETORICOXIB TABLET FORMULATIONS

A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF KETOPROFEN BY SOLID DISPERSION IN COMBINED CARRIERS

Asian Journal of Pharmacy and Life Science ISSN Vol. 2 (2), July-Sept,2012

ENHANCEMENT OF SOLUBILITY AND DISSOLUTION RATE OF NIMESULIDE BY CYCLODEXTRINS, POLOXAMER AND PVP

FORMULATION AND EVALUATION OF PIROXICAM AND CELECOXIB TABLETS EMPLOYING PROSOLVE BY DIRECT COMPRESSION METHOD

MEDAK DIST. ANDHRA PRADESH STATE, INDIA. Research Article RECEIVED ON ACCEPTED ON

Mixed Hydrotropy: Novel Science of Solubility Enhancement

FORMULATION AND CHARACTERIZATION OF TELMISATAN SOLID DISPERSIONS

RP-HPLC Analysis of Temozolomide in Pharmaceutical Dosage Forms

Available online at

A FACTORIAL STUDY ON ENHANCEMENT OF SOLUBILITY AND DISSOLUTION RATE OF IBUPROFEN BY β CYCLODEXTRIN AND SOLUTOL HS15

FACTORIAL STUDIES ON THE EFFECTS OF HYDROXY PROPYL β- CYCLODEXTRIN AND POLOXAMER 407 ON THE SOLUBILITY AND DISSOLUTION RATE OF BCS CLASS II DRUGS

EFFECT OF PVP ON CYCLODEXTRIN COMPLEXATION OF EFAVIRENZ FOR ENHANCING ITS SOLUBILITY AND DISSOLUTION RATE

Development and Validation of UV- Spectrophotometric Method for Estimation of Simvastatin in Bulk and Solid Dosage Form.

Biopharmaceutics Dosage form factors influencing bioavailability Lec:5

Advances in Prediction of Food Effects

Biowaiver Study on Prednisolone Tablets 5 mg in Three Different Brands. Marketed in Sudan. Safaa Mohamed *, Tilal Elsaman

A STUDY ON SUITABILITY OF NIMESULIDE-BETACYCLODEXTRIN COMPLEX IN ORAL AND TOPICAL DOSAGE FORMS

Chemate and Chowdary, IJPSR, 2012; Vol. 3(7): ISSN:

7. SUMMARY, CONCLUSION AND RECOMMENDATIONS

Research Article GALLIC ACID AND FLAVONOID ACTIVITIES OF AMARANTHUS GANGETICUS

DEVELOPMENT, VALIDATION AND APPLICATION OF THE HPLC METHOD FOR DETERMINATION OF MIANSERIN IN HUMAN SERUM

Asian Journal of Pharmacy and Life Science ISSN Vol. 1 (4), Oct-Dec, 2011

INTERNATIONAL JOURNAL OF INSTITUTIONAL PHARMACY AND LIFE SCIENCES

Comparative study of analytical method development of fluconazole in tablets and capsule by ultraviolet spectrophotometric method

Journal of Chemical and Pharmaceutical Research, 2018, 10(1): Research Article

Scholars Research Library

DEVELOPMENT OF UV SPECTROPHOTOMETRIC METHOD FOR THE ESTIMATION OF EZETIMIBE FROM TABLET FORMULATION

Int. Res J Pharm. App Sci., 2013; 3(6):42-46 ISSN:

Vol-3, Issue-4, Suppl-1, Nov 2012 ISSN: Patel et al PHARMA SCIENCE MONITOR

IN-VITRO RELEASE STUDY OF IBUPROFEN FROM DIFFERENT TOPICAL FORMULATIONS

ASSAY OF USING BETA-GLUCAZYME TABLETS

CHAPTER VI FACTORIAL STUDIES ON THE EFFECTS OF CYCLODEXTRINS AND SOLUTOL HS15 ON THE SOLUBILITY AND DISSOLUTION RATE OF EFAVIRENZ AND RITONAVIR

pharmaceutical formulations. Anagliptin shows absorption maximum at 246 nm and obeys beer s law in the

Development and Validation of a UV-Spectrophotometric Method for Quantification of Atorvastatin in Tablets

Bioequivalence Studies of Two Formulations of Famciclovir Tablets by HPLC Method

Preparation and Characterization of Candesartan Cilexetil Solid Lipid Nanoparticulate Capsules

Optimization of valsartan tablet formulation by 2 3 factorial design

International Journal of Pharma Sciences and Scientific Research

UV SPECTROPHOTOMETRIC METHOD DEVELOPMENT AND VALIDATION FOR THE DETERMINATION OF ATENOLOL AND LOSARTAN POTASSIUM BY Q-ANALYSIS

Journal of Chemical and Pharmaceutical Research

AZO-XYLAN (BIRCHWOOD)

SOLUBILITY OF SELECTED DERIVATIVES OF 1,4-BENZODIAZEPIN-2-ONE IN SOLID DISPERSIONS IN PEG 6000

Journal of Chemical and Pharmaceutical Research, 2018, 10(2): Research Article

IMPAIRMENT OF THE IN VITRO RELEASE OF CARBAMAZEPINE FROM TABLETS

Development and validation of spectrophotometric method for simultaneous estimation of Sumatriptan and Naproxen sodium in tablet dosage form

Comparative study of different solubility enhancement techniques on dissolution rate of zaltoprofen

Optimization of Enzyme-assisted Ultrasonic Extraction of Total Ginsenosides from Ginseng Roots Guangna LIU, Yulin ZUO, Jing ZHANG

0 9 : >?! 0 (.56± E

A FACTORIAL STUDY ON THE ENHANCEMENT OF DISSOLUTION RATE OF ACECLOFENAC BY SOLID DISPERSION IN STARCH PHOSPHATE AND GELUCIRE

DEVELOPMENT OF IN VITRO-IN VIVO CORRELATION FOR ENCAPSULATED METOPROLOL TARTRATE

IJPAR Vol.3 Issue 4 Oct-Dec-2014 Journal Home page:

Development, Estimation and Validation of Lisinopril in Bulk and its Pharmaceutical Formulation by HPLC Method

TENOFOVIR TABLETS: Final text for addition to The International Pharmacopoeia (June 2010)

FORMULATION DEVELOPMENT OF RIVAROXABAN LIPID SOLID DISPERSION USING DIFFERENT TECHNIQUES FOR THE DISSOLUTION ENHANCEMENT

ANALYTICAL METHOD DEVELOPMENT OF BICALUTAMIDE TABLET FOR DISSOLUTION TEST

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

Formulation and evaluation of sublingual tablets of lisinopril

Design and Optimization of Rivaroxaban Lipid Solid Dispersion for Dissolution Enhancement using Statistical Experimental Design. ), and Labrasol (X 3

International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-1, 2017, 1-7 Research Article Open Access.

Research Article Derivative Spectrophotometric Method for Estimation of Metformin Hydrochloride in Bulk Drug and Dosage Form

Date... Name... Group... Urine sample (Tube No 2)

Pelagia Research Library. Spectrophotometric method for simultaneous estimation of Valsartan and Hydrochlorothiazide in combined tablet dosage form

Lutein Esters from Tagetes Erecta

Spectrophotometric and HPLC Methods for Poorly Water Soluble Drugs

Vitamin C Assay Kit. ( DNPH method )

SOLID INCLUSION COMPLEXES OF CLASS II IMIDAZOLE DERIVATIVE WITH Β CYCLODEXTRIN. Pradesh.

endo-1,4-beta-xylanase

Development and Validation of Stability Indicating HPTLC Method for Estimation of Seratrodast

International Journal of Innovative Pharmaceutical Sciences and Research

DEVELOPMENT AND VALIDATION UV SPECTROPHOTOMETRIC METHOD FOR DETERMINATION OF ATENOLOL IN PURE MATERIALS AND PHARMACEUTICAL DOSAGE

Reverse Phase HPLC Analysis of Atomoxetine in Pharmaceutical Dosage Forms

This revision also necessitates a change in the table numbering in the test for Organic Impurities.

Determination of β2-agonists in Pork Using Agilent SampliQ SCX Solid-Phase Extraction Cartridges and Liquid Chromatography-Tandem Mass Spectrometry

Synergistic Effect of PEG-400 and Cyclodextrin to Enhance Solubility of Progesterone Submitted: November 20, 2002; Accepted: January 9, 2003

Comparative Dissolution Study of Glipizide by Solid Dispersion Technique

COMPARISON OF QUALITY CONTROL OF TWO DIFFERENT B-COMPLEX TABLETS AND THEIR LEGISLATIVE ISSUES ON THE ALBANIAN PHARMACEUTICAL MARKET

INTERNATIONAL RESEARCH JOURNAL OF PHARMACY ISSN Research Article

Asian Journal of Pharmaceutical Analysis and Medicinal Chemistry Journal home page:

>>> Oral Formulation Optimization. Introduction. A Tiered Approach for Identifying Enabling Formulations

Development and Validation of a New Uv Method for the Analysis of Rebamipide

AZO-WHEAT ARABINOXYLAN

The study the effect of polymer and surfactant concentration on characteristics of nanoparticle formulations

RP- HPLC and Visible Spectrophotometric methods for the Estimation of Meropenem in Pure and Pharmaceutical Formulations

Jan Meler, Bożena Grimling, Janusz Pluta

Quetiapine Tablets. Expert Committee Monographs Chemical Medicines 4 Reason for Revision Compliance

IJRPC 2011, 1(4) Rohan et al. ISSN: INTERNATIONAL JOURNAL OF RESEARCH IN PHARMACY AND CHEMISTRY

DEVELOPMENT AND VALIDATION OF NEW HPLC METHOD FOR THE ESTIMATION OF PALIPERIDONE IN PHARMACEUTICAL DOSAGE FORMS

ISSN: ; CODEN ECJHAO E-Journal of Chemistry 2011, 8(3),

Research and Reviews: Journal of Pharmacy and Pharmaceutical Sciences

ASSAY OF using AZO-FRUCTAN S-AZFR5 11/17

Abstract. G. D. Patil 1, P. G. Yeole 1, Manisha Puranik 1 and S. J. Wadher 1 *

FORMULATION AND EVALUATION OF VALSARTAN TABLETS EMPLOYING CYCLODEXTRIN-POLOXAMER 407-PVP K30 INCLUSION COMPLEXES

ENHANCEMENT OF SOLUBILITY, DISSOLUTION RATE AND BIOAVAILABILITY OF RITONAVIR BY CYCLODEXTRINS AND SOLUTOL HS15 - A FACTORIAL STUDY

3.1 Background. Preformulation Studies

Transcription:

Acta Poloniae Pharmaceutica ñ Drug Research, Vol. 72 No. 4 pp. 785ñ789, 2015 ISSN 0001-6837 Polish Pharmaceutical Society PHARMACEUTICAL TECHNOLOGY EFFECT OF STARCH HYDROLYSATES IN THE PROCESS OF DISSOLUTION OF SOLIDS PIOTR BELNIAK*, KATARZYNA åwi DER, MICHA SZUMI O, EWELINA PIETRZYK and EWA POLESZAK Chair and Department of Applied Pharmacy, Faculty of Pharmacy, Medical University, 1 Chodüki St., 20-093 Lublin, Poland Abstract: The purpose of this work was to investigate the influence of starch hydrolysates in the dissolution process of the substance practically insoluble in water. Progesterone and ibuprofen were chosen as model substances. The study was conducted with a constant amount of the drug (25 mg/ml) or constant amount of starch hydrolysate (50 mg/ml). Next, the influence of ethanolic solutions (10-30% v/v) on solubility of drug was tested. The results confirm the possibility of using starch hydrolysate as a cheap and safe addition to increase the solubility of practically insoluble drugs. Keywords: starch hydrolysate, dissolution of solids, progesterone, ibuprofen Nowadays in medicine, a large number of active substances, occurring in many forms and formulations, is being used. There are solid, semi-solid and liquid forms. Depending on the route of administration, the drug is liberated from formulation and dissolved in water or body liquids. So, drugís solubility and permeability are very important for the bioavailability. In accordance with the above physical properties, the Biopharmaceutics Classification System (BCS) categorizes drug into four classes (1). Solubility and dissolution rate are the most essential factors controlling the rate and extent of drug absorption. Inadequate aqueous solubility of therapeutically active entities is a great concern in pharmaceutical formulation, hence solubilization of insoluble or practically insoluble drugs in the formulation of various dosage forms, especially in parenteral medications has recently been in the centre of attention (2). A large group of substances used in medicine are compounds which are difficult to dissolve in water, so their bioavailability is not sufficient to obtain the optimal therapeutic effect. Hence, using a variety of techniques and methods, the aim is to ensure that the drug substance dissolves in water or body fluids. There are many techniques of increasing solubility of solids, for example by change of ph (1, 3, 4), using cosolvents (2, 5), hydrophilic additions (6, 7) or complex formation with cyclodextrins (8, 9), hydrotropic solubilization (10, 11) and formation of prodrugs (12, 13). Unfortunately, the amount of data on formulations containing starch hydrolysates is limited. Therefore, the purpose of this study was to demonstrate the effect of starch hydrolysis products on the solubility of the substance practically insoluble in water, such as ibuprofen and progesterone. EXPERIMENTAL Materials Starch (potato starch) used in this study was made by Nowamyl S.A. Lobez Poland. Progesterone (PR) was purchased from Fluka Chemie, Switzerland, ibuprofen (IB) IOL Chemicals and Pharmaceuticals Ltd., Ludhiana, India. Citric acid (CA), glacial acetic acid (GAA), ethanol (760 g/ml, ET) and sodium hydroxide (4 g/l, SO) were purchased from POCh Poland. Hydrolysis of starch Starch was treated with solutions of CA, GAA and water at 95 O C for 2 or 4 h to obtain starch hydrolysate SH2 or SH4 respectively. Received sed- * Corresponding author: e-mail: piotr.belniak@umlub.pl 785

786 PIOTR BELNIAK et al. iments were cleaned by ET and evaporated to eliminate the solvent (14). Molecular mass of obtained hydrolysates were estimated in cryoscope (Trident 800 CL) by freezing point determination. Molecular mass of SH2 amounts 2.356 kda and 1.105 kda for SH4. Analytical methods Analytical dilution of pure IB and PR were prepared in SO and ET (10% w/w), respectively. Their absorbances were taken at 263 nm for IB and 249 nm for PR on spectrometer Helios Omega UV- VIS (Thermo Scientific) and were plotted against their respective concentrations to obtain standard curve. The amount of IB and PR was calculated from standard curve. Solubility determination The solubility extent of IB and PR in water was measured in three steps. Figure 1. The effect of increasing amount of SH on dissolution of ibuprofen, (n = 5) Figure 2. The effect of increasing amount of SH on dissolution of progesterone, (n = 5)

Effect of starch hydrolysates in the process of dissolution of solids 787 Figre 3. The effect of constant amount of SH (50 mg/ml) on dissolution of ibuprofen, (n = 5) Figure 4. The effect of constant amount of SH (50 mg/ml) on dissolution of progesterone, (n = 5) In the first, solutions 10% w/v of SH2 and SH4 were made. Next, with constant quantity of IB or PR (25 mg/ml), amount of SH solutions (v) were increased from 0 ml up to 10 ml and water was added to obtain the same volume. Test tubes were closed for 24 h and shaken temporary, then, suspensions were centrifuged with 5000 rpm (centrifuge machine, MPW-223e Med. Instruments, Poland) and 3 ml of the supernatant liquid was diluted up to 25 ml with suitable solvent - SO or ET (10% w/w). The absorbance was determined spectrophotometrically at appropriate wavelength. Determined concentrations of IB and PR (n = 5) are shown in Figures 1 and 2. In the second step, with constant quantity of SH2 or SH4 (50 mg/ml), the amount of IB and PR were increased according to Table 1. Trials were prepared and examined as above. Determined concentrations of IB and PR (n = 5) are shown in Figures 3 and 4. In the third step, influence of addition of ET was examined. Solutions of SH2 or SH4 (50 mg/ml) were prepared in ET 10%, 20% and 30% (v/v). The amount of IB or PR were added accord-

788 PIOTR BELNIAK et al. Figure 5. The effect of constant amount of SH (50 mg/ml) on dissolution of ibuprofen in ethanolic solution (10, 20, 30% v/v), (n = 5) Figure 6. The effect of constant amount of SH (50 mg/ml) on dissolution of progesterone in ethanolic solution (10, 20, 30% v/v), (n = 5) Table 1. Concentrations of ibuprofen and progesterone in trials Trial No. Concentration of ibuprofen Concentration of progesterone C ref. (µg/ml) C ref. (µg/ml) 1 2.94 0.29 2 5.88 0.59 3 11.76 1.18 4 29.41 2.94 5 58.82 5.88 6 88.24 8.82 7 117.65 11.76

Effect of starch hydrolysates in the process of dissolution of solids 789 ing to Table 1. Trials were prepared and examined as above. Determined concentrations of IB and PR (n = 5) are shown in Figures 5 and 6. RESULTS AND DISCUSSION The effect of starch hydrolysates in the process of dissolution of drugs practically insoluble in water was assessed. The best composition of the addition of SH was tried to find, so it was decided to divide tests in three steps. The first ñ with constant quantity of drug, the second ñ with constant quantity of SH, and the third ñ with addition of solutions of ethanol ñ 10%, 20% and 30% (v/v). In the first phase, solubility of IB and PR increased with increasing addition of SH2 or SH4 solution. It was noticed, that addition of 10 ml of SH2 or SH4 solution caused the increase of solubility of IB ñ 3.22 or 3.54 times, respectively, and for PR the increase was on level 2.97 or 2.71 times, respectively, for SH2 or SH4. None of increases was linear, so it was chosen the average amount of solution of SH ñ 5 ml which corresponding to 50 mg/ml of SH. In the next phase, the presence of SH helped to dissolve added IB in 100% up to 5.88 mg/ml, greater amounts of IB were not completely dissolved, at the highest concentration of tested IB (117.65 mg/ml), dissolution was on level of 17%. The presence of SH2 also helped to dissolve 100% added PR up to 5.88 mg/ml, while the presence of SH4 caused complete dissolution of PR up to 1.18 mg/ml. At the highest concentration of PR (11.76 mg/ml), SH2 and SH4 helped to dissolve 62.2% and 69.4% of drug, respectively. In the third phase, solutions of ET additionally increased dissolution of tested drugs. Solution of ET 10% (v/v) did not affect on dissolution of IB and at the highest concentration of IB only 11.3% was dissolved, for solutions of ET 20%, 30% it was 20.9% and 27.3%, respectively. Better situation was observed during dissolution of PR, with increasing concentration of drug, in the presence of solution of ET 10, 20 and 30%, increased concentration of dissolved PR. At the highest concentration of PR, it was 69.9, 81.2 and 96.3% of dissolved PR, respectively. CONCLUSION The presence of starch hydrolysates increases three times dissolution of drug practically insoluble in water. Differences between SH2 and SH4, in the process of dissolution arenít significant. Solutions of ET 10ñ30% additionally enhance dissolution of drug. The use of starch hydrolysates in the process of dissolution of drug practically insoluble in water seems promising. REFERENCES 1. Sheng J.J., Kasim N.A., Chandrasekharan R., Amidon G.L.: Eur. J. Pharm. Sci. 29, 306 (2006). 2. Kov cs K., Stampf G., Klebovich I., Antal I., Lud nyi K.: Eur. J. Pharm. Sci. 36, 352 (2009). 3. Chakraborty S., Shukla D., Jain A., Mishra B., Singh S.: J. Colloid Interface Sci. 335, 242 (2009). 4. Cirri M., Maestrelli F., Corti G., Furlanetto S., Mura P.: J. Pharm. Biomed. Anal. 42, 126 (2006). 5. Marsza L.: Pharmacy World (Polish) 11, 57 (2007). 6. Bodek K. H.: Acta Pol. Pharm. Drug Res. 59, 105 (2002). 7. wiertnia B.: Acta Pol. Pharm. Drug Res. 65, 487 (2008). 8. Hanna K., de Brauer Ch., Germain P.: J. Environ. Manage. 71, 1 (2004). 9. Yang G., Jain N., Yalkowsky S.H.: Int. J. Pharm. 269, 141 (2004). 10. Maheshwari R.K., Indurkhya A.: Asian J. Pharm. 3, 235 (2010). 11. Revathi R., Ethiraj T., Saravanan V.S., Ganeshan V., Saeanya V. et al.: Int. J. Pharm. Pharm. Sci. 2, 74 (2010). 12. Brandi G., Rossi L., Schiavano G.F., Millo E., Magnani M.: Int. J. Antimicrob. Agents 34, 177 (2009). 13. Stella V.J., Nti-Addae K.W.: Adv. Drug Deliv. Rev. 59, 677 (2007). 14. Czarnecki W. Belniak P.: Patent Office Bulletin (Polish) 4, 13 (2007). Received: 24. 06. 2014